GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Valeo Pharma Inc (TSX:VPH) » Definitions » Cash Flow for Lease Financing

Valeo Pharma (TSX:VPH) Cash Flow for Lease Financing : C$0.00 Mil (TTM As of Jan. 2024)


View and export this data going back to 2019. Start your Free Trial

What is Valeo Pharma Cash Flow for Lease Financing?

Valeo Pharma's Cash Flow for Lease Financing for the three months ended in Jan. 2024 was C$0.00 Mil. Valeo Pharma's Cash Flow for Lease Financing for the trailing twelve months (TTM) ended in Jan. 2024 was C$0.00 Mil.

Compared with last quarter (C$0.00 Mil in Oct. 2023 ), Valeo Pharma's Cash Flow for Lease Financing remained the same in Jan. 2024 (C$0.00 Mil).


Valeo Pharma Cash Flow for Lease Financing Historical Data

The historical data trend for Valeo Pharma's Cash Flow for Lease Financing can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Valeo Pharma Cash Flow for Lease Financing Chart

Valeo Pharma Annual Data
Trend Oct17 Oct18 Oct19 Oct20 Oct21 Oct22 Oct23
Cash Flow for Lease Financing
Get a 7-Day Free Trial - - - - -

Valeo Pharma Quarterly Data
Apr19 Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24
Cash Flow for Lease Financing Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Valeo Pharma Cash Flow for Lease Financing Calculation

Cash Flow for Lease Financing is change in cash flow resulting from increase or decrease in lease financing.


Cash Flow for Lease Financing for the trailing twelve months (TTM) ended in Jan. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was C$0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Valeo Pharma Cash Flow for Lease Financing Related Terms

Thank you for viewing the detailed overview of Valeo Pharma's Cash Flow for Lease Financing provided by GuruFocus.com. Please click on the following links to see related term pages.


Valeo Pharma (TSX:VPH) Business Description

Traded in Other Exchanges
Address
16667, Hymus Boulevard, Kirkland, QC, CAN, H9H 4R9
Valeo Pharma Inc is a Canadian specialty pharmaceutical company focused on acquiring either through acquisitions, in-licensing, or similar arrangements. The company operates in two divisions: Branded prescription products and Niche hospital injectable products. Its product portfolio includes medicines for Respiratory/Allergy, Ophthalmology, Neurology, and Oncology.
Executives
Luc Mainville Senior Officer

Valeo Pharma (TSX:VPH) Headlines

No Headlines